Segment Reporting

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting. We report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology medical device products which assist in diagnosing and treating coronary artery disease, peripheral vascular disease and other non-vascular diseases and includes our embolotherapeutic products. Our endoscopy segment consists of gastroenterology and pulmonary medical device products which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. We evaluate the performance of our operating segments based on operating income (loss). Financial information relating to our reportable operating segments and reconciliations to the consolidated totals is as follows (in thousands):

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2013		2012			2013		2012
Revenues
Cardiovascular	$	105,953	$	96,560		$	205,707	$	188,230
Endoscopy	3,922		3,972			8,116		7,920
Total revenues	109,875		100,532			213,823		196,150
Operating income (loss)
Cardiovascular	6,649		8,499			8,277		16,836
Endoscopy	131		(277		)	260		(607		)
Total operating income	$	6,780	$	8,222		$	8,537	$	16,229